Si-Bone (SIBN) EBITDA (2017 - 2026)

Si-Bone's EBITDA history runs 10 years deep, the most recent figure standing at -$5.1 million for Q1 2026.

• On a quarterly basis, EBITDA rose 31.91% year-over-year to -$5.1 million in Q1 2026; TTM through Mar 2026 was -$19.9 million, a 35.01% increase from a year earlier, with the FY2025 full-year figure at -$22.3 million, up 36.65% from the prior year.
• EBITDA fell to -$5.1 million in Q1 2026 per SIBN's latest filing, from -$2.5 million in the prior quarter.
• Across five years, EBITDA topped out at -$2.5 million in Q4 2025 and bottomed at -$17.9 million in Q2 2022.
• The 5-year median for EBITDA is -$11.2 million (2023), against an average of -$10.0 million.
• Across the five-year window, EBITDA sank 45.73% in 2022 and soared 56.07% in 2024, its largest moves.
• Year by year, EBITDA stood at -$11.3 million in 2022, then retreated by 10.73% to -$12.5 million in 2023, then surged by 56.07% to -$5.5 million in 2024, then soared by 55.17% to -$2.5 million in 2025, then tumbled by 106.78% to -$5.1 million in 2026.
• Per Business Quant, the three latest SIBN EBITDA figures stand at -$5.1 million (Q1 2026), -$2.5 million (Q4 2025), and -$5.4 million (Q3 2025).